Researcher in immunotherapy. Rohaan and collaborators compared tumor-infiltrating lymphocyte therapy with ipilimumab in advanced melanoma, directly testing alternative treatment strategies rather than inferring benefit from immune activity alone.[ref]
Articles by others on the same topic
There are currently no matching articles.